Trials / Unknown
UnknownNCT03126058
Enhanced Recovery After Surgery Program for Colorectal Cancer: a Multi-center Study (ERASC1)
Enhanced Recovery After Surgery Program for Colorectal Cancer: a Multi-center Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,000 (estimated)
- Sponsor
- Jinling Hospital, China · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is aimed to evaluate the safety of applying enhanced recovery after surgery for colorectal cancer.
Detailed description
In China, Europe and America, colorectal cancer is one of common malignant tumors. It is very important for treatment of colorectal cancer to enhance the quality of treatment, increase patients' survival rate and improve the life quality. So far, surgical resection is optimal treatment for patients with colorectal cancer. As a result, increasing the quality of surgery and improving the perioperative managements have a great influence on patients received a coloproctectomy. Investigators have spent over ten years studying enhanced recovery after surgery programs for colorectal cancer and have got some successful experience. Investigators found enhanced recovery after surgery can accelerate patients' recovery without increasing complications. This study is the first multi-center study of enhanced recovery after surgery for colorectal cancer in China. During this period, the study is aimed to evaluate the safety of applying enhanced recovery after surgery for colorectal cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | enhanced recovery after surgery | Patients will undergo enhanced recovery after surgery programs. |
Timeline
- Start date
- 2017-06-21
- Primary completion
- 2018-08-31
- Completion
- 2018-12-31
- First posted
- 2017-04-24
- Last updated
- 2018-04-30
Locations
23 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03126058. Inclusion in this directory is not an endorsement.